Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma

by M. K. Ramirez‐Fort, B. Meier‐Schiesser, K. Lachance, S. S. Mahase, C. D. Church, M. J. Niaz, H. Liu, V. Navarro, A. Nikolopoulou, D. V. Kazakov, E. Contassot, D. P. Nguyen, J. Sach, L. Hadravsky, Y. Sheng, S. T. Tagawa, X. Wu, C. S. Lange, L. E. French, P. T. Nghiem, N. H. Bander
Published 2021-03-01